Description

JUVÉDERM VOLITE with Lidocaine is a sterile cross-linked hyaluronic acid injectable gel implant manufactured by Allergan. It is intended for professional treatment of superficial skin depressions, including fine lines, and for improvement of skin-quality characteristics such as hydration and elasticity.

Each 1 ml syringe contains 12 mg of hyaluronic acid gel and 3 mg of lidocaine hydrochloride. A standard box contains two 1 ml prefilled syringes and four sterile, single-use 32G ½-inch needles.

What is JUVÉDERM VOLITE?

JUVÉDERM VOLITE is a skin-quality injectable within the professional JUVÉDERM collection. The product is a sterile, clear, physiological gel containing cross-linked hyaluronic acid of non-animal origin.

Unlike firmer JUVÉDERM products developed to restore structural facial volume, VOLITE has a lower hyaluronic acid concentration and is intended for intradermal professional treatment of superficial skin concerns.

The official instructions identify fine superficial lines, hydration and elasticity among the relevant skin-quality characteristics. Authorised indications can vary between markets, so practitioners must follow the instructions supplied with the actual product.

JUVÉDERM VOLITE product specifications

• Product name: JUVÉDERM VOLITE with Lidocaine
• Product type: Cross-linked hyaluronic acid injectable gel implant
• Hyaluronic acid: 12 mg per 1 ml syringe
• Lidocaine hydrochloride: 3 mg per 1 ml syringe
• Lidocaine concentration: 0.3%
• Individual syringe volume: 1 ml
• Pack size: Two prefilled syringes
• Total gel volume: 2 ml
• Needles included: Four sterile 32G ½-inch single-use needles
• Manufacturer: Allergan
• Manufacturing location: France
• Product format: Sterile prefilled disposable syringe
• Intended user: Authorised and appropriately qualified medical practitioners

Key features of JUVÉDERM VOLITE

JUVÉDERM VOLITE combines cross-linked hyaluronic acid with lidocaine in a smooth injectable gel. It is intended to provide intradermal physical support for superficial skin depressions while supporting the appearance of hydrated and elastic skin.

The product is supplied in graduated, prefilled syringes. A standard box also includes sterile needles, instructions for use and labels intended to support patient and batch traceability.

VOLITE contains 0.3% lidocaine. According to the manufacturer, the local anaesthetic is included to help reduce pain during professional administration. It does not remove all discomfort or eliminate the risks associated with an injectable procedure.

Hyaluronic acid and lidocaine

Hyaluronic acid: Each syringe contains 12 mg of cross-linked hyaluronic acid gel. Hyaluronic acid can bind water and is used in professional injectable products intended to provide temporary physical support within the skin.

Lidocaine hydrochloride: Each 1 ml syringe contains 3 mg of lidocaine hydrochloride. Patients must disclose any previous allergy or sensitivity to lidocaine or other amide local anaesthetics.

The formulation also contains a phosphate buffer adjusted to pH 7.2. The enclosed instructions should be consulted for the complete composition, contraindications, precautions and possible adverse effects.

VOLITE compared with VOLUMA and VOLUX

VOLITE, VOLUMA and VOLUX are separate products with different compositions and intended professional roles:

• JUVÉDERM VOLITE: Contains 12 mg HA per 1 ml and is intended for superficial skin depressions and skin-quality characteristics.
• JUVÉDERM VOLUMA: Contains 20 mg HA per 1 ml and is intended to restore facial volume.
• JUVÉDERM VOLUX: Contains 25 mg HA per 1 ml and is intended to restore and create facial volume.

All three contain 3 mg of lidocaine hydrochloride per 1 ml syringe. They should not be presented or used as interchangeable products.

Professional consultation and suitability

JUVÉDERM VOLITE must only be administered by an authorised healthcare professional with suitable anatomical knowledge, product training, insurance and legal authority. It is not intended for self-injection or home use.

A consultation should consider medical conditions, medication, allergies, previous injectable treatments, permanent implants, skin condition and treatment expectations.

The official instructions identify contraindications and precautions that must be assessed. These include known sensitivity to hyaluronic acid, lidocaine, amide local anaesthetics or relevant bacterial proteins.

Potential risks, complications, alternatives and aftercare should be explained before treatment. Individual experiences can vary, and no exact result or duration should be guaranteed.

Important restrictions

The official instructions state that JUVÉDERM VOLITE should not be injected into the eyelids or blood vessels. It must not be used for breast augmentation or reconstruction.

The product should not be used in areas affected by active inflammation or infection. Additional restrictions apply to certain medical conditions and patient groups, so the complete instructions must be reviewed before treatment.

This safety summary is not an injection protocol. It does not replace formal training, professional judgement or the manufacturer’s complete directions for use.

Packaging and authenticity checks

Inspect every JUVÉDERM VOLITE box before professional use. Confirm the product name, manufacturer, two-syringe presentation, batch number, expiry date, seals and traceability labels.

Do not use the product if the box, sterile packaging, syringe or needle packaging appears damaged, opened or altered. Products whose authenticity or storage history cannot be verified should not be administered.

Retain the invoice, original packaging, batch information and patient traceability labels. These records may be required if a product complaint or safety incident needs to be investigated.

Storage and responsible handling

Store JUVÉDERM VOLITE according to the conditions printed on the original packaging and instructions. Keep the product sealed, protected from unsuitable conditions and secured against unauthorised access.

Each syringe and needle is intended for single-patient use. Opened, used, damaged or expired products must be disposed of according to applicable infection-control, sharps and clinical-waste procedures.

Important regulatory information

This page provides general commercial product information. It is not medical advice, an injection protocol or confirmation that every international indication applies in the United Kingdom.

Purchasers are responsible for verifying authenticity, conformity marking, regulatory status and permitted use. Professionals must read and follow the instructions supplied with their specific box.

For complete manufacturer information, review the official JUVÉDERM VOLITE instructions for use. You can also browse professional products from The Clinic Vault shop.

Order JUVÉDERM VOLITE

A standard box contains two 1 ml prefilled syringes and four sterile 32G ½-inch needles. Before ordering, confirm that the packaging, regional version, expiry date and conformity information meet your professional requirements.

Add JUVÉDERM VOLITE to your basket when ready, or contact The Clinic Vault for clarification about availability or packaging. This medical device is supplied for authorised professional use and must not be self-administered.